Full Year 2021 Cosmo Pharmaceuticals NV Earnings Call Transcript
Ladies and gentlemen, welcome to the Cosmo Full Year 2021 Results and 2022 Outlook Conference Call and Webcast. I am Alice, the Chorus Call operator. (Operator Instructions) And the conference is being recorded. The presentation will be followed by a Q&A session. (Operator Instructions) The conference must not be recorded for publication or broadcast.
At this time, it's my pleasure to hand over to Alessandro Della Chà , Chief Executive Officer. Please go ahead, sir.
Good afternoon, everyone. Thank you very much for joining our presentation of the full year 2021 results and outlook for 2022. So let's start with a quick introduction for those who don't know us already, and let's explain who we are, first of all.
So Cosmo is a pharmaceutical company that develops and manufactures innovative products in three fields: one is gastroenterology, the other one is dermatology and the third one is health tech. In gastroenterology, we develop drugs to treat
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
